Got a Healthcare IT Renovation Project? We Have a DIY Book for You!

 

Given the rise of digital transformation demands and the persistent challenges of cybersecurity, a healthcare IT renovation project can be pivotal as industry leaders actively seek guidance on navigating these complex waters.

Why now? What makes the current landscape ripe for a Healthcare IT Renovation Project, and how does one tackle such a monumental task without a roadmap?

Welcome to Healthcare Rethink, a FinThrive Podcast hosted by Brian Urban. This episode examines the nuts and bolts of healthcare IT renovation with guest Susan Snedaker, CIO at El Rio Health and author of “Renovating Healthcare IT: Building the Foundation for Digital Transformation.” This discussion spans the strategic implementation of IT frameworks to addressing real-time challenges faced by healthcare professionals today.

The main points of the conversation include:

  • Strategies for integrating robust cybersecurity measures in healthcare IT systems
  • Best practices for digital transformation in healthcare settings, ensuring both efficiency and compliance
  • The impact of IT renovations on patient care quality and operational efficiency

Susan Snedaker brings a wealth of experience and insight to the table. Before joining El Rio Health as CIO, she honed her skills in various IT roles, including working for Microsoft and as a healthcare IT consultant. Susan’s background includes an MBA and extensive experience in the technical and strategic aspects of IT management in healthcare. Her accolades in the industry are a testament to her deep commitment to enhancing healthcare through technology.

Recent Episodes

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…